CohBar, Inc. CohBar, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Overview
    • Platform Technology
    • Pipeline
  • News & Media
    • Press Releases
    • Publications
    • Events
    • Media
    • Newsroom
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications
  • Events
  • Media
  • Newsroom

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

Feb 21, 2017

CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York

Feb 9, 2017

CohBar Inc. Presentation Now Available for On-Demand Viewing

Feb 6, 2017

CohBar Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2

Feb 1, 2017

CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises

Jan 11, 2017

CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco

Jan 10, 2017

CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents

Dec 6, 2016

CohBar, Inc. Announces Third Quarter 2016 Financial Results

Nov 14, 2016

CohBar, Inc.’s CEO Simon Allen to Present at BIO Investor Forum 2016

Oct 18, 2016

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Oct 13, 2016
    • 1...
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    © 2021 CohBar, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap